Re: Additional Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Exempt Distribution

in response to

Additional Exempt Distribution

KOO-KOO2

posted on Oct 30, 2023 09:22AM

Two additional Exempt Distribution

1) 2023-10-11 (Alberta)

Promissory Note: $374,082.50 (CAN)

With 500,000 warrants @ $1.02, Expire 2028-10-10.

2) 2023-10-25 (Alberta)

Promissory Note: $516,825.00 (CAN)

With 650,000 warrants @ $1.03, Expire 2028-10-25

Koo

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply